indapamide has been researched along with Dizzyness in 5 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study, carried out in three centers in the United States, investigated the antihypertensive effect of three dosages of indapamide in 87 patients with mild to moderate hypertension." | 9.05 | Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension. ( Bolton, S; Capone, P; Neiss, ES; Reeves, RL; Vukovich, RA, 1983) |
| "Perindopril/indapamide treatment resulted in a statistically significant higher fall in both BP (-3." | 6.71 | Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. ( De Leeuw, PW; Erdogan, G; Halimi, S; Hamani, A; Hess, B; Jermendy, G; Luger, A; Mechmeche, R; Mogensen, CE; Nolan, J; Ribeiro, A; Ritz, E; Ruilope, L; Rull, J; Sanchez, R; Sareli, P; Scheen, A; Sirotiakova, J; Taton, J; Thomas, SM; Viberti, G; Widimsky, J, 2003) |
| "5 mg SR formulation of indapamide has an improved antihypertensive efficacy : safety ratio, which is in accordance with international recommendations for the use of low-dose antihypertensive drugs and diuretics in first-line therapy of hypertension." | 5.08 | Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. ( Ambrosioni, E; de Cordoüe, A; Degaute, JP; Guez, D; MacMahon, M; Malin, PL; Pujol, DR; Safar, M, 1998) |
| "This study, carried out in three centers in the United States, investigated the antihypertensive effect of three dosages of indapamide in 87 patients with mild to moderate hypertension." | 5.05 | Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension. ( Bolton, S; Capone, P; Neiss, ES; Reeves, RL; Vukovich, RA, 1983) |
| "Perindopril/indapamide treatment resulted in a statistically significant higher fall in both BP (-3." | 2.71 | Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. ( De Leeuw, PW; Erdogan, G; Halimi, S; Hamani, A; Hess, B; Jermendy, G; Luger, A; Mechmeche, R; Mogensen, CE; Nolan, J; Ribeiro, A; Ritz, E; Ruilope, L; Rull, J; Sanchez, R; Sareli, P; Scheen, A; Sirotiakova, J; Taton, J; Thomas, SM; Viberti, G; Widimsky, J, 2003) |
| "Indapamide is an antihypertensive agent similar to thiazides, but with some different effects." | 2.71 | Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. ( Algun, E; Can, S; Ceylan, K; Dogan, E; Erkoc, R; Gonulalan, H; Sayarlioglu, H; Topal, C; Yilmaz, Y, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mogensen, CE | 1 |
| Viberti, G | 1 |
| Halimi, S | 1 |
| Ritz, E | 1 |
| Ruilope, L | 1 |
| Jermendy, G | 1 |
| Widimsky, J | 1 |
| Sareli, P | 1 |
| Taton, J | 1 |
| Rull, J | 1 |
| Erdogan, G | 1 |
| De Leeuw, PW | 1 |
| Ribeiro, A | 1 |
| Sanchez, R | 1 |
| Mechmeche, R | 1 |
| Nolan, J | 1 |
| Sirotiakova, J | 1 |
| Hamani, A | 1 |
| Scheen, A | 1 |
| Hess, B | 1 |
| Luger, A | 1 |
| Thomas, SM | 1 |
| Ceylan, K | 1 |
| Topal, C | 1 |
| Erkoc, R | 1 |
| Sayarlioglu, H | 1 |
| Can, S | 1 |
| Yilmaz, Y | 1 |
| Dogan, E | 1 |
| Algun, E | 1 |
| Gonulalan, H | 1 |
| Capone, P | 1 |
| Vukovich, RA | 1 |
| Neiss, ES | 1 |
| Bolton, S | 1 |
| Reeves, RL | 1 |
| Ambrosioni, E | 1 |
| Safar, M | 1 |
| Degaute, JP | 1 |
| Malin, PL | 1 |
| MacMahon, M | 1 |
| Pujol, DR | 1 |
| de Cordoüe, A | 1 |
| Guez, D | 1 |
| Asmar, RG | 1 |
| London, GM | 1 |
| O'Rourke, ME | 1 |
| Safar, ME | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fixed-Dose Combination of Perindopril/Amlodipine (Amlessa®) and Fixed-Dose Combination of Perindopril/Indapamide /Amlodipine (Co-Amlessa®) - Contribution to Management in Newly Diagnosed and Uncontrolled Hypertensive Patients[NCT03738761] | Phase 4 | 471 participants (Actual) | Interventional | 2018-02-13 | Completed | ||
| Longitudinal Change of Arterial Stiffness Indices in Relation to Ambulatory Aortic and Branchial Pressure in Long Term Peritoneal Dialysis Patients[NCT03607747] | 40 participants (Anticipated) | Observational | 2018-07-18 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for indapamide and Dizzyness
| Article | Year |
|---|---|
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Cough; Diabetes Mellitus, Type 2; | 2003 |
Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Calcium; Calcium Metabolism Disorders; Creatinine; D | 2005 |
Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Dizziness; Dose-Response Relations | 1983 |
Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
Topics: Adult; Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; De | 1998 |
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Ao | 2001 |